MPH Health Care Past Earnings Performance
Past criteria checks 2/6
MPH Health Care's earnings have been declining at an average annual rate of -51.5%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been declining at an average rate of 34.9% per year. MPH Health Care's return on equity is 13.1%, and it has net margins of 95.1%.
Key information
-51.5%
Earnings growth rate
-51.6%
EPS growth rate
| Pharmaceuticals Industry Growth | 14.1% |
| Revenue growth rate | -34.9% |
| Return on equity | 13.1% |
| Net Margin | 95.1% |
| Next Earnings Update | 07 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How MPH Health Care makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 31 | 29 | 1 | 0 |
| 30 Sep 22 | 10 | -20 | 1 | 0 |
| 30 Jun 22 | -11 | -68 | 1 | 0 |
| 31 Mar 22 | 1 | -39 | 1 | 0 |
| 31 Dec 21 | 14 | -9 | 1 | 0 |
| 30 Sep 21 | 18 | -12 | 1 | 0 |
| 30 Jun 21 | 22 | -14 | 1 | 0 |
| 31 Mar 21 | 13 | -42 | 1 | 0 |
| 31 Dec 20 | 3 | -70 | 1 | 0 |
| 30 Sep 20 | 20 | -37 | 1 | 0 |
| 30 Jun 20 | 38 | -3 | 1 | 0 |
| 31 Mar 20 | 39 | 4 | 1 | 0 |
| 31 Dec 19 | 41 | 11 | 1 | 0 |
| 30 Sep 19 | 19 | -13 | 1 | 0 |
| 30 Jun 19 | -3 | -37 | 1 | 0 |
| 31 Mar 19 | 21 | 0 | 1 | 0 |
| 31 Dec 18 | 45 | 37 | 1 | 0 |
| 30 Sep 18 | 64 | 63 | 1 | 0 |
| 30 Jun 18 | 84 | 90 | 1 | 0 |
| 31 Mar 18 | 59 | 61 | 1 | 0 |
| 31 Dec 17 | 34 | 32 | 1 | 0 |
| 30 Sep 17 | 22 | 45 | 1 | 0 |
| 30 Jun 17 | 10 | 58 | 0 | 0 |
| 31 Mar 17 | 10 | 69 | 1 | 0 |
| 31 Dec 16 | 9 | 80 | 1 | 0 |
| 30 Sep 16 | 83 | 90 | 3 | 0 |
| 30 Jun 16 | 156 | 100 | 5 | 0 |
| 31 Mar 16 | 210 | 91 | 7 | 0 |
| 31 Dec 15 | 263 | 83 | 8 | 0 |
| 30 Sep 15 | 239 | 43 | 9 | 0 |
| 30 Jun 15 | 214 | 3 | 10 | 0 |
| 31 Mar 15 | 217 | 4 | 8 | 0 |
| 31 Dec 14 | 219 | 5 | 6 | 0 |
| 30 Sep 14 | 226 | 6 | 6 | 0 |
| 30 Jun 14 | 232 | 7 | 0 | 0 |
| 31 Mar 14 | 229 | 7 | 0 | 0 |
| 31 Dec 13 | 227 | 6 | 6 | 0 |
| 30 Sep 13 | 223 | 9 | 3 | 0 |
| 30 Jun 13 | 219 | 12 | 0 | 0 |
| 31 Mar 13 | 212 | 13 | 0 | 0 |
| 31 Dec 12 | 206 | 15 | 0 | 0 |
| 30 Sep 12 | 190 | 13 | 1 | 0 |
| 30 Jun 12 | 175 | 11 | 2 | 0 |
Quality Earnings: 0W1Q has high quality earnings.
Growing Profit Margin: 0W1Q became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0W1Q's earnings have declined by 51.5% per year over the past 5 years.
Accelerating Growth: 0W1Q has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 0W1Q has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-41.9%).
Return on Equity
High ROE: 0W1Q's Return on Equity (13.1%) is considered low.